# Connected Drug Delivery Devices * **Definition:** Connected Drug Delivery Devices are medical devices that integrate digital technology to enhance the administration of medications, allowing for real-time monitoring, data collection, and communication with healthcare providers or patients, thereby improving adherence, safety, and efficacy of treatment. * **Taxonomy:** Healthcare Topics / Connected Drug Delivery Devices ## News * Selected news on the topic of **Connected Drug Delivery Devices**, for healthcare technology leaders * 1.5K news items are in the system for this topic * Posts have been filtered for tech and healthcare-related keywords | Date | Title | Source | | --- | --- | --- | | 5/15/2025 | [**10 Cutting-Edge Health Tech Software Solutions Revolutionizing Disease Management**](https://medium.com/@ajay.singh_91430/10-cutting-edge-health-tech-software-solutions-revolutionizing-disease-management-48b8766a63fa) | [[Medium]] | | 4/30/2025 | [**AI Transparency in Healthcare: Navigating a Changing Regulatory Landscape - JD Supra**](https://www.jdsupra.com/legalnews/ai-transparency-in-healthcare-3671487/) | [[JD Supra]] | | 3/10/2025 | [**Connected Drug Delivery Devices Patent Landscape Report 2024 - Yahoo Finance**](https://finance.yahoo.com/news/connected-drug-delivery-devices-patent-160900509.html) | [[Yahoo Finance]] | | 3/5/2025 | [**CMO: Provider organizations should deploy AI where it solves real pain points**](https://www.healthcareitnews.com/news/cmo-provider-organizations-should-deploy-ai-where-it-solves-real-pain-points) | [[Healthcare IT News]] | | 3/2/2025 | [**Can AI Outperform Doctors in Diagnosing Infectious Diseases?**](https://www.news-medical.net/health/Can-AI-Outperform-Doctors-in-Diagnosing-Infectious-Diseases.aspx) | [[News Medical Net]] | | 2/24/2025 | [**Compounding Pharmacy Market Size to Reach US$ 26,838.8 Mn by 2034, Expanding at 6.5 ...**](https://finance.yahoo.com/news/compounding-pharmacy-market-size-reach-130700283.html) | [[Yahoo Finance]] | | 2/13/2025 | [**Vial Adaptors for Reconstitution Drug Market to Reach USD 4,146.27 by 2032, Growing at a ...**](https://www.prnewswire.com/news-releases/vial-adaptors-for-reconstitution-drug-market-to-reach-usd-4-146-27-by-2032--growing-at-a-7-24-cagr--credence-research-302376298.html) | [[PR Newswire]] | | 2/9/2025 | [**MultiCare cuts $2.5M in unnecessary healthcare costs**](https://www.beckershospitalreview.com/quality/multicare-cuts-2-5m-in-unnecessary-healthcare-costs/) | [[Beckers Hospital Review]] | | 2/7/2025 | [**Healthcare IT Market to Grow by USD 215.4 Billion from 2025-2029, Driven by Service Quality and Efficiency Focus, with AI Impact on Market Trends - Technavio**](https://www.prnewswire.com/news-releases/healthcare-it-market-to-grow-by-usd-215-4-billion-from-2025-2029--driven-by-service-quality-and-efficiency-focus-with-ai-impact-on-market-trends---technavio-302371183.html) | [[PR Newswire]] | | 1/29/2025 | [**How genAI and precision medicine will change healthcare in 2025**](https://www.healthcareitnews.com/news/how-genai-and-precision-medicine-will-change-healthcare-2025) | [[Healthcare IT News]] | | 1/9/2025 | [**Connected Drug Delivery Devices Research Report 2024: Global Market to Reach $22.9 ...**](https://finance.yahoo.com/news/connected-drug-delivery-devices-research-091700828.html) | [[Yahoo Finance]] | | 1/9/2025 | [**Connected Drug Delivery Devices Research Report 2024-2030, Profiles of ... - Business Wire**](https://www.businesswire.com/news/home/20250109025545/en/Connected-Drug-Delivery-Devices-Research-Report-2024-2030-Profiles-of-Adherium-Aterica-Biocorp-FindAir-Merck-Phillips-Medisize-Propeller-Health-Proteus-Digital-Health-West-Pharmaceutical---ResearchAndMarkets.com) | [[Business Wire]] | | 1/9/2025 | [**Connected Drug Delivery Devices Research Report 2024-2030, Profiles of Adherium, Aterica, Biocorp, FindAir, Merck, Phillips Medisize, Propeller Health, Proteus Digital Health, West Pharmaceutical - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20250109025545/en/Connected-Drug-Delivery-Devices-Research-Report-2024-2030-Profiles-of-Adherium-Aterica-Biocorp-FindAir-Merck-Phillips-Medisize-Propeller-Health-Proteus-Digital-Health-West-Pharmaceutical---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 1/9/2025 | [**Pharmaceutical Cartridges Strategic Research Report 2024-2030: Increased Focus on Patient-Centric Drug Delivery Solutions Strengthens the Business Case for Pharmaceutical Cartridges - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20250109458995/en/Pharmaceutical-Cartridges-Strategic-Research-Report-2024-2030-Increased-Focus-on-Patient-Centric-Drug-Delivery-Solutions-Strengthens-the-Business-Case-for-Pharmaceutical-Cartridges---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/20/2024 | [**Infusion Pump Market is expected to generate a revenue of USD 24.09 Billion by 2031 ...**](https://finance.yahoo.com/news/infusion-pump-market-expected-generate-150000232.html) | [[Yahoo Finance]] | | 11/22/2024 | [**Global Medical Imaging Outsourcing Market: Trends Analysis and Future Growth Prospects (2024**](https://www.linkedin.com/pulse/global-medical-imaging-outsourcing-market-trends-analysis-5etof) | [[Linkedin]] | | 11/5/2024 | [**Connected Drug Delivery Devices Market Forecast Report to 2035, Profiling Leading Companies Bigfoot Biomedical, BIOCORP, Eitan Medical, EoFlow, Insulet, Medtronic, Medtrum, Sonceboz, Ypsomed & More - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241105175986/en/Connected-Drug-Delivery-Devices-Market-Forecast-Report-to-2035-Profiling-Leading-Companies-Bigfoot-Biomedical-BIOCORP-Eitan-Medical-EoFlow-Insulet-Medtronic-Medtrum-Sonceboz-Ypsomed-More---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/31/2024 | [**Drug Device Combination Products Strategic Market Research 2024-2030: Increasing Collaborations Between Pharmaceutical and Medical Device Companies, and Growing Investments in R&D Bolster Growth - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241031101217/en/Drug-Device-Combination-Products-Strategic-Market-Research-2024-2030-Increasing-Collaborations-Between-Pharmaceutical-and-Medical-Device-Companies-and-Growing-Investments-in-RD-Bolster-Growth---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 9/2/2024 | [**Connected Drug Delivery Devices Market Detailed Size and Forecast Report for 2032**](https://www.whatech.com/og/markets-research/medical/874283-connected-drug-delivery-devices-market-detailed-size-and-forecast-report-for-2032.html) | whatech.com | | 8/26/2024 | [**Integrated Delivery Networks Market Advancements Highlighted by Size, Share ... - WhaTech**](https://www.whatech.com/og/markets-research/it/871333-integrated-delivery-networks-market-size-share-industry-trends-growth-competitive-landscape-demand-forecast-2033.html) | whatech.com | | 6/27/2024 | [**Healthcare Analytics Information, News and Tips - TechTarget**](https://www.techtarget.com/healthtechanalytics/) | techtarget.com | | 2/6/2022 | [**Four emerging data integration trends to assess**](https://www.computerweekly.com/feature/Four-emerging-data-integration-trends-to-assess) | [[Computer Weekly]] | | 9/7/2021 | [**Clover Health to integrate Assistant tool into athenahealth electronic medical record**](https://www.fiercehealthcare.com/payer/clover-health-to-integrate-assistant-tool-into-athenahealth-ehrs) | [[FierceHealthcare]] | | 11/13/2019 | [**CMS to implement new appropriate use criteria for advanced diagnostic imaging in 2020**](https://www.fiercehealthcare.com/practices/starting-january-1-cms-will-implement-new-appropriate-use-criteria-for-advanced) | [[FierceHealthcare]] | | 5/3/2017 | [**Dignity Health fights sepsis with natural language processing, targeted alerts**](https://www.fiercehealthcare.com/analytics/dignity-health-fights-sepsis-house-analytics-targeted-alerts) | [[FierceHealthcare]] | ## Topic Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **BD (Becton, Dickinson and Company)**: A leader in connected drug delivery devices, focusing on prefilled syringes and infusion pumps. - **Ypsomed**: A pioneer in device-enabled digital health solutions that integrate drug delivery devices with advanced connectivity features. - **Dose.com**: Set to launch the Dose Patch, an innovative smart patch system for automated medication delivery. - **Medtronic**: A major player in the medical device industry, focusing on connected drug delivery solutions for chronic disease management. - **Medtronic Inc.**: A major player in the medical technology field, contributing to innovations in connected drug delivery systems. - **BD**: A leading global medical technology company that is innovating with smart, connected devices to enhance treatment outcomes. - **Glooko, Inc.**: A leader in digital health solutions, focusing on enhancing patient management and adherence through connected drug delivery devices. - **Becton, Dickinson and Company**: A leading global medical technology company that focuses on advancing connected drug delivery devices through extensive patent filings. - **Novartis**: Collaborating with Lindy Biosciences to develop self-administered drug delivery systems. - **Sanofi SA**: A multinational pharmaceutical company that is actively involved in the development of connected drug delivery devices to enhance patient adherence. - **Insulet**: A company known for its Omnipod insulin management system, which integrates connected drug delivery technology. - **Lyndra Therapeutics**: A company developing long-acting oral therapies that aim to improve medication adherence through innovative drug delivery platforms. - **TriSalus Life Sciences**: A company specializing in Pressure-Enabled Drug Delivery (PEDD) technology aimed at improving therapeutic delivery to solid tumors. - **ZEM Life Watch**: Developed a wearable technology that automates the delivery of Narcan for opioid overdose reversal. - **QHSLab Inc.**: Developing the AIR-GUIDDE project to enhance drug delivery efficiency using advanced computational fluid dynamics. - **Aptar Digital Health**: A company offering a comprehensive ecosystem of digital health solutions designed to improve patient experiences and outcomes through innovative technologies. - **Key Player**: Pfizer Inc., Definition: A major player in the pharmaceutical industry, involved in the development of innovative drug delivery technologies. - **Klotho Neurosciences**: A company developing gene therapies for neurodegenerative diseases, including ALS and Alzheimer's, utilizing innovative drug delivery systems. - **Superior Sensor Technology**: A company that has expanded its CP Series Dual Pressure Sensors, enhancing capabilities in medical applications. ### Partnerships and Collaborations - **PDA Conference**: The upcoming conference aims to foster collaborations among pharmaceutical, biotech, and drug delivery companies to enhance therapy effectiveness. - **Strategic collaborations among pharmaceutical companies**: These collaborations are fostering innovation and market growth in the drug-device combination products sector. - **Glooko and Innovation Zed**: A strategic partnership to develop digital companion apps for managing injectable therapies, enhancing patient management and adherence. - **QHSLab Inc. and NSF**: Collaboration to advance the AIR-GUIDDE project for improved drug delivery efficiency. - **Novartis and Lindy Biosciences**: Strategic collaboration to develop self-administered versions of innovative drugs using Microglassifiction technology. - **Commure and Tenet Healthcare Corporation**: Partnering to implement an ambient AI platform to enhance healthcare technology innovation. - **CommonWealth Purchasing Group and BridgeHealthAI**: A strategic partnership aimed at enhancing social care coordination for Federally Qualified Health Centers (FQHCs) across the U.S. - **Aptar Digital Health and University of Geneva**: Collaborating to advance migraine research by monitoring digital biomarkers and their relationship with migraine occurrences. - **Amrita Vishwa Vidyapeetham and Hikigai**: A memorandum of understanding to establish a research center focused on AI in healthcare, including advancements in drug delivery. - **Phrase Health and Wolters Kluwer Health**: Collaborating to integrate clinical decision support solutions into electronic health records, enhancing management of clinical guidelines. - **Lyndra Therapeutics and Thermo Fisher Scientific**: A collaboration to provide clinical research services for Lyndra's phase 3 pivotal safety study of oral weekly risperidone. - **SoCalBio Conference**: This event will highlight life science innovations and provide a platform for investors to meet emerging companies in the healthcare sector. ### Innovations, Trends, and Initiatives - **Connected Drug Delivery Devices**: Integration of digital health technologies with drug delivery systems to enhance patient self-care and therapy management. - **Patient Engagement**: Connected drug delivery devices are improving patient adherence to treatment regimens, crucial for managing chronic diseases like diabetes and asthma. - **Technological Advancements**: Integration of AI, mobile app technology, and real-time data analytics is enhancing the functionality and user-friendliness of connected drug delivery devices. - **Digital Companion Apps**: The development of digital solutions that integrate with existing platforms to support patients on injectable therapies, addressing complex dosing regimens. - **Development of smart drug delivery systems and digital health technologies.**: Innovations such as microneedle patches, smart inhalers, and wireless infusion pumps are enhancing patient compliance and therapeutic effectiveness. - **Smart Drug Delivery Systems**: The market for smart drug delivery systems is expected to grow, with connected inhalers projected to generate significant revenue due to rising chronic disease prevalence. - **Dose Patch**: An innovative smart patch that automates medication delivery and provides real-time data on patient adherence. - **AI Integration**: Artificial Intelligence is being utilized to enhance diagnostics, treatment adherence, and patient monitoring in connected drug delivery devices. - **Wearable Neurotechnology**: Emerging trends in wearable devices, including ZEM Life Watch's automated Narcan delivery system, highlight advancements in connected drug delivery. - **Market Growth**: The connected drug delivery devices market is projected to grow from approximately $5.8 billion in 2023 to $22.9 billion by 2030, reflecting a CAGR of 21.7%. - **Patent Trends**: The US leads in patent filings for connected drug delivery devices, with over 5,000 patents, indicating a strong focus on technological integration. - **Medical Smart Textiles**: Integration of advanced textile technologies into healthcare is enabling real-time health monitoring and drug delivery. - **Nanorobots in Healthcare**: Nanorobots are being developed for targeted drug delivery and complex diagnostics, showcasing significant potential for personalized medicine. - **AIR-GUIDDE Project**: Utilizes advanced computational fluid dynamics to improve drug deposition in respiratory systems. - **Peptide-based Drug Delivery**: A new approach using specially designed peptides to improve drug formulations, significantly enhancing anti-tumor efficacy in leukemia models. - **Inhalable Therapeutics**: Researchers have developed a novel inhalable drug delivery system for lung cancer using mucoadhesive protein nanoparticles, enhancing targeted delivery. - **Wearable Tech in Healthcare**: Expected growth driven by advancements in technology and increasing health awareness, with a focus on real-time data collection. ### Challenges and Concerns - **Data Privacy and Security**: As connected drug delivery devices collect sensitive patient data, concerns regarding data privacy and security are paramount. - **Device failures and the need for user-friendly designs.**: Manufacturers must address these issues to ensure the reliability and accessibility of connected drug delivery devices. - **Regulatory Challenges**: The integration of AI in connected drug delivery devices faces regulatory hurdles that may slow down adoption and innovation. - **Patient Adherence**: Despite advancements in drug delivery technologies, ensuring patient adherence remains a significant challenge, particularly with complex dosing regimens. - **Market Barriers**: High costs and limited accessibility of advanced drug delivery systems pose challenges, particularly in price-sensitive regions. - **Patient Safety and Data Privacy**: Concerns regarding patient safety and data privacy are paramount as connected devices collect and transmit sensitive health information. - **Data Integration**: As healthcare technology evolves, effective data integration becomes crucial for real-time insights and operational efficiency, posing challenges for organizations. - **Security Risks**: The rise of connected medical devices raises concerns about data security and the need for robust cybersecurity measures to protect sensitive health information. - **High costs of advanced infusion pumps and stringent regulatory compliance requirements.**: These factors pose significant hurdles for market growth, necessitating a focus on cost-effective solutions and quality assurance. - **Market Adoption Barriers**: Challenges include cross-border regulatory issues, misaligned incentives within healthcare systems, and lack of interoperability. - **Non-compliance**: Approximately 50% of patients do not adhere to their prescribed medication regimens, leading to significant healthcare costs and poor health outcomes. - **Regulatory Environment**: The medtech industry faces challenges related to regulatory compliance, particularly as companies navigate shifts in corporate strategies and market demands. - **Regulatory Compliance**: Stringent regulatory guidelines from organizations like the FDA and WHO influence market expansion and adoption of new technologies. - **Investment Decline in Cell and Gene Therapies**: Challenges in manufacturing and drug delivery have led to a significant drop in investment in this sector. - **Regulatory Hurdles**: The pharmaceutical industry faces challenges such as regulatory compliance complexities and the need for rigorous clinical trials, which can hinder drug development. ## Related Topics [[Med Device]]